drugset / Trial / NCT02375217
"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"
RandomizedParallel-groupTriple-blindTreatment
Summary
Prospective Randomized non inferiority Trial involving adult patients undergoing elective surgery under general anesthesia.56 Patients will be enrolled in 2 groups : full dose sugammadex vs half dose sugammadex for reversal of NMB.
Timeline
- Start
- 2014-10
- Primary completion
- 2015-10
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neostigmine | Other / unclassified | 50 ug/kg | Intravenous |
| Comparator | Sugammadex | Other / unclassified | 1 mg/kg | Intravenous |
| Comparator | Sugammadex | Other / unclassified | 2 mg/kg | Intravenous |
| Comparator | Sugammadex | Other / unclassified | 4 mg/kg | Intravenous |
| Comparator | Glycopyrrolate | Small molecule | 10 ug/kg | — |
Indications
No indication recorded.